Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing innovative therapeutics. Key products include Purified Cortrophin® Gel for rare diseases and intravitreal implants ILUVIEN® and YUTIQ® for chronic retinal conditions. With a robust pipeline and recent acquisition of Alimera Sciences, ANI targets growth in rare diseases and generics, aiming to enhance patient care and expand its market presence globally.
This description was generated via AI from an annual report. Updated about 1 year ago.